Hexagon Nutrition IPO GMP: Grey Market Premium, Date, Price, and Key Details
Hexagon Nutrition IPO will open from 5 June 2026. Check latest GMP, IPO dates, price band, lot size, financials, reservation details and company overview.
Quick Summary
Hexagon Nutrition IPO GMP Overview: Hexagon Nutrition IPO worth ₹138.87 Cr will open for subscription from 5 Jun to 9 Jun 2026. Hexagon allotment is expected on 10 Jun and shares are likely to be listed on BSE & NSE on 12 Jun 2026. Price band for Hexagon IPO is set between ₹42 to ₹45 per share and as of 29 May 2026, Hexagon Nutrition GMP today stands Flat.
Hexagon Nutrition IPO: Hexagon Nutrition is set to launch its IPO and the company has filed a Red Herring Prospectus (RHP) with SEBI for an issue size of ₹138.87 crore. The public issue is completely an Offer for Sale (OFS), which means the company will not receive any fresh funds from the IPO.
Here are the key dates and important details investors should know about the upcoming IPO.
Hexagon Nutrition IPO Details
-
Hexagon Nutrition’s IPO is worth ₹138.87 cr and is entirely an offer for sale.
-
Hexagon Nutrition’s ipo will open for subscription on 5 Jun 2026 and close on 9 Jun 2026. And the price band is set between ₹42-₹45.
-
Hexagon Nutrition’s allotment is likely to take place on 10 Jun 2026 and the shares are expected to be listed on BSE and NSE on 12 Jun 2026.
-
Promoters currently hold 89.41%, which will come down after IPO listing to 64.29%. The company’s market cap stands at around ₹553.13 crore.
-
Kfin Technologies will be the registrar for Hexagon IPO.
|
Parameter |
Detail |
|
IPO Open Date |
5 Jun 2026 |
|
IPO Close Date |
9 June 2026 |
|
Expected Listing Date |
12 June 2026 (BSE & NSE) |
|
Price Band |
₹42 – ₹45 per share |
|
Lot Size |
333 shares |
|
Minimum Investment |
₹13,986 |
|
Fresh Issue |
- |
|
Offer for Sale (OFS) |
₹138.87 crore |
|
Total Issue Size |
₹138.87 crore |
Hexagon Nutrition IPO GMP Today
Hexagon Nutrition IPO GMP today (30 May 2026) stands at ₹0, indicating no premium in the grey market currently. GMP figures change daily based on market sentiment and demand for the IPO.
Investors should note that grey market premium is unofficial and not regulated by SEBI. GMP only reflects informal market trends and should not be considered a guaranteed indicator of listing gains.
GMP figures are for news purposes only. We neither trade nor recommend trading in grey market.
Hexagon Nutrition IPO Reservation
For Hexagon Nutrition IPO, 35% of the issue has been reserved for retail investors. The table below shows the allocation across different investor categories.
|
Investor Category |
Shares Offered |
|
QIB Investors |
50% |
|
Retail Investors |
35% |
|
NII (HNI) Investors |
15% |
Hexagon Nutrition IPO Lot Size
Retail investors can apply for a minimum of 1 lot, which includes 333 shares costing ₹14,985. Maximum investment allowed for retail investors is 13 lots, which totals 4,329 shares and costs ₹1,94,805.
|
Application |
Lots |
Shares |
Amount |
|
Retail (Min) |
1 |
333 |
₹14,985 |
|
Retail (Max) |
13 |
4,329 |
₹1,94,805 |
|
S-HNI (Min) |
14 |
4,662 |
₹2,09,790 |
|
S-HNI (Max) |
66 |
21,978 |
₹9,89,010 |
|
B-HNI (Min) |
67 |
22,311 |
₹10,03,995 |
About Hexagon Nutrition IPO
Founded in 1993, Hexagon Nutrition is a nutrition-focused company that develops and manufactures health and wellness products. The company operates in areas such as micronutrient premixes, clinical nutrition, therapeutic nutrition products, and ready-to-use nutritional foods.
Hexagon Nutrition has manufacturing plants in India, along with one overseas facility in Tashkent, Uzbekistan.
The company’s business is divided into 3 segments:
-
Branded wellness and clinical nutrition products for consumers,
-
Premix formulations for businesses.
-
Ready-to-use foods and micronutrient powders under ESG and public health initiatives.
Its well-known brands include Pentasure, Obesigo, Pediagold, and Nutrone. Between FY23 and FY25, Hexagon Nutrition exported products to more than 75 countries across Asia, Africa, Europe, and South America. As of 31 March 2026, the company had 527 employees.
Hexagon Nutrition Financial Performance
Hexagon Nutrition reported a PAT of ₹24 Cr as of 31 March 2025, and in FY24 reported ₹12 Cr. Over the past 3 years, the company’s PAT and PAT margin have been growing continuously. All financial details are provided in the table below.
|
Period Ended |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Revenue from Ops (₹ Cr) |
324.93 |
297.73 |
278.50 |
|
Total Income (₹ Cr) |
331.29 |
304.62 |
281.65 |
|
EBITDA (₹ Cr) |
40.07 |
24.88 |
17.17 |
|
EBITDA Margin (%) |
12.33% |
8.36% |
6.17% |
|
PAT (₹ Cr) |
24.38 |
12.21 |
5.82 |
|
PAT Margin (%) |
7.36% |
4.01% |
2.07% |
|
ROE (%) |
10.47% |
7.21% |
3.50% |
|
ROCE (%) |
17.06% |
11.12% |
5.94% |
|
Debt-to-Equity Ratio |
0.14 |
0.21 |
0.3 |
Source: Hexagon Nutrition RHP
Hexagon Nutrition IPO Peer Comparison from RHP
Hexagon Nutrition has poor EPS compared to its peers. Higher EPS is always considered better. Below is a brief comparison of Hexagon Nutrition.
|
Company |
Revenue from Operations (₹ Cr) |
EPS (Diluted, ₹) |
P/E (x) |
|
Hexagon Nutrition |
324.93 |
1.75 |
- |
|
Zydus Wellness |
2,780.90 |
10.90 |
46.22 |
|
Nestlé India |
20,201.56 |
16.63 |
88.86 |
As of 31 March 2025
PEOPLE ALSO READING : CMR Green Technologies IPO GMP